Brief: ANI Pharmaceuticals Announces Buyout Of Royalty Obligation For Iluvien And Yutiq
18/03/2025 10:55
March 18 (Reuters) - ANI Pharmaceuticals Inc ANIP.O: ANI PHARMACEUTICALS ANNOUNCES BUYOUT OF ROYALTY OBLIGATION FOR ILUVIEN® AND YUTIQ® ANI PHARMACEUTICALS INC - COMPLETES BUYOUT OF 3.125% ROYALTY OBLIGATION FOR $17.25 MILLION Source text: ID:nGNX1HcCVY Further company coverage: ANIP.O ((Reuters.Briefs@thomsonreuters.com))
Recent news on ANI Pharmaceuticals
See all newsBrief: Ani Pharmaceuticals Announces The Launch Of Duloxetine Delayed-Release Capsules
Brief: Ani Pharmaceuticals Announces The FDA Approval Of Everolimus Tablets For Oral Suspension
Brief: Ani Pharmaceuticals Appoints Henry Gosebruch To Board Of Directors
U.S. RESEARCH ROUNDUP-Compass Minerals, Duke Energy, Tesla
ANI Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary